Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Common Equity (2016 - 2025)

Historic Common Equity for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $4.4 million.

  • Jaguar Health's Common Equity fell 6671.76% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 6671.76%. This contributed to the annual value of $6.5 million for FY2024, which is 3261.18% up from last year.
  • Jaguar Health's Common Equity amounted to $4.4 million in Q3 2025, which was down 6671.76% from $6.9 million recorded in Q2 2025.
  • Jaguar Health's 5-year Common Equity high stood at $31.9 million for Q1 2021, and its period low was -$1.4 million during Q4 2022.
  • Over the past 5 years, Jaguar Health's median Common Equity value was $6.9 million (recorded in 2025), while the average stood at $10.0 million.
  • Its Common Equity has fluctuated over the past 5 years, first surged by 195861.4% in 2021, then crashed by 11144.01% in 2022.
  • Quarter analysis of 5 years shows Jaguar Health's Common Equity stood at $11.9 million in 2021, then plummeted by 111.44% to -$1.4 million in 2022, then skyrocketed by 461.14% to $4.9 million in 2023, then skyrocketed by 32.61% to $6.5 million in 2024, then crashed by 32.88% to $4.4 million in 2025.
  • Its Common Equity was $4.4 million in Q3 2025, compared to $6.9 million in Q2 2025 and $830000.0 in Q1 2025.